ATXI - Avenue Therapeutics Inc. Kapitalizatsiyaning sotish hajmiga nisbati

Avenue Therapeutics Inc. (ATXI) kompaniyasining korporativ logotipi

Avenue Therapeutics o'zining xavfsiz dori portfeli tufayli yuqori narx belgilash imkoniyatiga ega. GURU.Markets platformasida kompaniyaning joriy P/S koeffitsiyenti bozor baholashini aks ettiradi, bunda belgisi ushbu parametrni xarakterlaydi. Biznes klinikalarga mo'ljallangan bog'liqlikni keltirib chiqarmaydigan IV Tramadol ishlab chiqishga tayanadi, intensiv R&D loyihalari esa titroq va markaziy asab tizimining o'tkir holatlariga yo'naltirilgan molekulalarga e'tibor qaratadi.

ATXI: Avenue Therapeutics, Inc P/S multiplikatori 04.07.2022 - 17.11.2026

Avenue Therapeutics Inc (ATXI) kompaniyasining tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:Avenue Therapeutics, Inc. - ATXI
Avenue Therapeutics, Inc tayyor mahsulotlari

Bozor kapitalizatsiyasining yillik daromadga nisbati bozorni operatsion daromadning har bir birligi uchun qancha premium to'lashga tayyorligini o'lchaydi va kelajakdagi pul oqimlariga bo'lgan ishonch darajasini aks ettiradi. Markaziy nerv tizimi (CNS) ishlanmalarining ilk bosqichlarida bo'lgan Avenue Therapeutics (ATXI) uchun kompaniyaning o'rtacha P/S ko'rsatkichi klinik bosqichlar kutilmalari asosidagi spekulyativ baholashni aks ettiradi, bunda grafikdagi keskin tebranishlar cho'qqi nuqtalarda haddan tashqari yuqori narx to'lash xavfi haqida signal beradi.

Raqobatdosh kompaniyalar

BIIB (Biogen) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NBIX (Neurocrine Corp)|Regencell Bioscience - Narxning daromadga nisbati|Axsome Therapeutics - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Narxning daromadga nisbati|Sotuvga nisbatan narx Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - P/S multiplikatori|CPRX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DNLI|Narx/daromad koeffitsiyenti Harmony Biosciences|Biohaven Ltd - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Praxis Corp PRAX|AVXL: P/S multiplikatori|CBLL (ceribell.com) - Narxning daromadga nisbati|PRTA (Prothena Corporation) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati alector.com (ALEC)|Narxning daromadga nisbati Annexon, Inc. (ANNX)|OMER - Sotuvga nisbatan narx|P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Sotuvga nisbatan narx|Voyager Therapeutics Inc - P/S multiplikatori|Neumora (NMRA) - Kapitalizatsiyaning daromadga nisbati|SCLX: P/S multiplikatori|TVGN - Narx/daromad koeffitsiyenti|ACOG (Alpha Cognition Inc) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati cogrx.com (CGTX)|Narxning daromadga nisbati Inhibikase Therapeutics Inc (IKT)|Narx/daromad koeffitsiyenti Cassava Sciences|P/S multiplikatori ASRT (Assertio Holdings)|COYA - Kapitalizatsiyaning daromadga nisbati|vistagen.com - P/S multiplikatori|OVID: Narxning daromadga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Narxning daromadga nisbati|CervoMed Inc - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Alterity Therapeutics Limited|clene.com (CLNN) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati PEPG (PepGen Inc)|P/S multiplikatori jupiterneurosciences.com (JUNS)|Narxning daromadga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: Kapitalizatsiya va daromad nisbati|Grace Tx - P/S multiplikatori|AIFF (Firefly Neuroscience Inc) - Kapitalizatsiya va daromad nisbati|KLTO: P/S multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - P/S multiplikatori|Narxning daromadga nisbati Reviva Pharmaceuticals, Inc.|Kapitalizatsiyaning daromadga nisbati metaviatx.com (MTVA)|P/S multiplikatori NRXS|HSDT - Sotuvga nisbatan narx|Passage Bio, Inc. - Kapitalizatsiyaning daromadga nisbati|bionomics.com.au (NEUP) - Sotuvga nisbatan narx|Minerva - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ATHA (Athira Pharma Inc)|ADXN: P/S multiplikatori|Kapitalizatsiya va daromad nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - P/S multiplikatori|PTIX (Protagenic Therapeutics) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori KTTA|Narx/daromad koeffitsiyenti Cortigent|Narxning daromadga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Bozor kapitallashuvining daromadga nisbati CARA|chromocell.com - P/S multiplikatori|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|Sotuvga nisbatan narx Longboard Pharmaceuticals, Inc. (LBPH)|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGN: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NRBO|SAGE: Narxning sotuvga nisbati|Synaptogenix Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - P/S multiplikatori|Anew Medical (WENA) - Kapitalizatsiyaning daromadga nisbati|CERE (Cerevel Corp) - Kapitalizatsiyaning daromadga nisbati